Before it's here, it's on the Bloomberg Terminal.Learn More
Key Statistics
P/E Ratio--
Bloomberg (BEst) P/E Ratio--
Bloomberg (BEst) PEG Ratio--
Shares Outstanding14.66M
Price to Book Ratio8.5101
Price to Sales Ratio16.3874
1 Year Return-31.87%
30 Day Avg Volume3,912
EPS-1.00
Bloomberg (BEst) EPS Curr Yr-0.8250
Dividend--
Last Dividend Reported--
Earnings Announcement for Period Ending Q3/2018:09/28/2018
About GeNeuro SA
GeNeuro SA operates as a clinical stage pharmaceutical company. The Company develops therapeutic drugs for diseases associated with the expression of pathogenic proteins of human endogenous retroviral origin. GeNeuro focuses on nervous system diseases, such as multiple sclerosis and schizophrenia.Address
18, Chemin Des Aulx
Plan-Les-Ouates, CH-1228
Switzerland